查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1461372

子宮內人工授精器市場：現況分析與預測（2023-2030）

Intrauterine Insemination Devices Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 139 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

由於全球不孕症的普遍存在，子宮內人工授精裝置市場預計將以約 3.7% 的穩定速度成長。 例如，根據世界衛生組織 (WHO) 的統計，全世界六分之一的人在一生中都會經歷不孕的經歷。 在預測期內，有幾個因素正在推動市場成長，例如尋找有效治療方法的臨床試驗數量的增加、醫療保健產業投資的增加。 除此之外，子宮內人工授精設備的加速上市增加了對有效治療的需求，這也穩步推動了子宮內人工授精設備市場。

依產品類型，市場分為子宮內授精導管和子宮內授精精子清潔器。 由於不孕症患者的增加，子宮腔內人工授精的精子清潔裝置市場在2022年佔據主導地位。 子宮腔內人工授精 精子清洗是在人工授精過程中準備將精子插入子宮的過程。 這涉及從精液樣本中分離健康、活動的精子，並去除潛在的有害物質，如前列腺素、細菌和死精子。 因此，在產品類型中，子宮內人工授精精子清潔細分市場在2022年佔據了重要的市場佔有率。

根據最終用戶，市場分為醫院、IVF 診所等。 在預測期內，由於醫院患者數量不斷增加，診所部門預計將在市場中佔據主要佔有率。 診所部門在子宮內人工授精 (IUI) 設備市場中發揮重要作用，因為診所是子宮內人工授精 (IUI) 服務的主要提供者。 此細分市場包括生育診所、生殖健康中心和提供輔助生殖技術 (ART) 服務的醫院。 影響這一領域的主要因素包括子宮內人工授精設備的技術進步、對不孕症治療的認識不斷提高以及對替代懷孕方法的需求不斷增長。 此外，監管政策、報銷情況和患者偏好等因素也會影響 IUI 設備市場中診所部門的動態。 因此，在預測期內，診所類別在最終用戶中將表現出更高的複合年增長率。

為了更瞭解市場，市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、西班牙、義大利、歐洲其他地區）、亞太地區（中國、日本、印度、亞太地區其他地區）和世界其他地區。 由於不孕症患者的快速增加、醫療保健成本的增加以及引入創新進步的舉措和投資的增加，北美在 2022 年目前的情況下將主導市場。 例如，美國 Mosie Baby 的家用人工授精套件於 2023 年 12 月獲得 FDA 批准。 由於該地區不孕症病例的增加，政府機構啟動了提高意識計畫。 這樣一來，依地區劃分，2022年北美將佔據很大一部分市場佔有率。

市場上營運的主要公司包括 CooperSurgical Fertility Company、Cook Group Incorporated、Vitrolife Scotland AB、Kitazato Corporation、FUJIFILM Irvine Scientific、MEDGYN PRODUCTS, INC.、Rocket Medical plc.、Thomas Medical、Famasys Inc.、Allwin Medical Medical設備等。

目錄

第一章市場介紹

  • 市場定義
  • 主要目標
  • 利害關係人
  • 限制

第二章研究方法或前提

  • 調查過程
  • 調查方法
  • 受訪者簡介

第三章市場總結

第 4 章執行摘要

第五章 COVID-19 對子宮內人工授精設備市場的影響

第六章2020-2030年宮內人工授精裝置市場收入

第七章依產品類型進行市場分析

  • 子宮內人工授精導管
    • 彎曲型
    • 靈活
    • 線性型
  • 子宮內人工授精精子清潔裝置

第 8 章最終用戶市場分析

  • 醫院
  • 診所
  • 其他

第九章區域市場分析

  • 北美
    • 美國
    • 加拿大
    • 其他北美地區
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區

第十章宮內人工授精器市場動態

  • 市場驅動因素
  • 市場課題
  • 影響分析

第十一章宮內人工授精器市場機會

第十二章宮內人工授精器市場趨勢

第十三章供需分析

  • 需求方分析
  • 供給面分析

第14章價值鏈分析

第15章比賽場景

  • 競爭狀況
    • 波特五力分析

第十六章公司簡介

  • CooperSurgical Fertility Company
  • Cook Group Incorporated
  • Vitrolife Sweden AB
  • Kitazato Corporation
  • FUJIFILM Irvine Scientific
  • MEDGYN PRODUCTS, INC.
  • Rocket Medical plc.
  • Thomas Medical
  • Femasys Inc.
  • Allwin Medical Devices

第十七章免責聲明

簡介目錄
Product Code: UMHE212677

Intrauterine insemination (IUI) is a fertility treatment where sperm is directly inserted into a woman's uterus to facilitate fertilization. It's often used when there are issues with sperm motility or when the cause of infertility is unexplained. It's a less invasive and less expensive option compared to in vitro fertilization (IVF). Intrauterine insemination (IUI) devices are specialized tools used by healthcare providers to perform the procedure. These devices are designed to facilitate the placement of sperm directly into the uterus, optimizing the chances of fertilization during the IUI procedure. A rising number of clinical trials and technological advancements are leading to the market's growth. Several other factors, such as rising research & development activities, rising healthcare expenditure, rising regulatory support, and a surge in government collaborations & partnerships are driving the intrauterine insemination devices market globally.

The Intrauterine Insemination Devices Market is expected to grow at a steady rate of around 3.7% owing to the growing prevalence of infertility globally. For instance, according to the World Health Organization, globally one in six people experience infertility in their lifetime. Several factors, including a rising number of clinical trials to find effective treatment, and rising investments in healthcare departments are driving the market's growth during the forecast period. Apart from this, the accelerated launch of intrauterine insemination devices has resulted in higher demand for effective treatment procedures which are also driving this market of intrauterine insemination devices at a steady rate.

Based on the product type, the market is bifurcated into intrauterine insemination catheters and intrauterine insemination sperm wash. The intrauterine insemination sperm wash segment dominated the market in the year 2022 owing to the rising cases of infertility. Intrauterine insemination sperm wash is a process used to prepare sperm for insertion into the uterus during the IUI procedure. It involves separating healthy, motile sperm from the semen sample and removing potentially harmful substances such as prostaglandins, bacteria, and dead sperm. Thus, among the product types, the intrauterine insemination sperm wash segment held a significant market share in 2022.

Based on the end user, the market is categorized into hospitals, IVF clinics, and others. The clinic segment is expected to hold a significant share of the market in the forecast period owing to the rising patient load in hospitals. The clinics segment plays a vital role in the intrauterine insemination (IUI) device market, as clinics are the primary providers of IUI services. This segment encompasses fertility clinics, reproductive health centers, and hospitals offering assisted reproductive technology (ART) services. Key factors influencing this segment include technological advancements in IUI devices, increasing awareness about fertility treatments, and rising demand for alternative conception methods. Additionally, factors such as regulatory policies, reimbursement scenarios, and patient preferences also impact the dynamics of the clinic segment within the IUI device market. Thus, the clinics category will witness a higher CAGR amongst end users during the forecast period.

For a better understanding, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the surge in cases of infertility, rising healthcare expenditure, and rising initiatives and investments in introducing innovative advancements. For instance, in December 2023, U.S.-based Mosie Baby got FDA clearance for its at-home artificial insemination kit. Government organizations are initiating infertility awareness programs for the sake of the growing cases in the region. Thus, amongst regions, North America held a significant share of the market in 2022.

Some of the major players operating in the market include CooperSurgical Fertility Company; Cook Group Incorporated; Vitrolife Sweden AB; Kitazato Corporation; FUJIFILM Irvine Scientific; MEDGYN PRODUCTS, INC.; Rocket Medical plc.; Thomas Medical; Femasys Inc.; Allwin Medical Devices.

TABLE OF CONTENTS

1.MARKET INTRODUCTION

  • 1.1.Market Definitions
  • 1.2.Main Objective
  • 1.3.Stakeholders
  • 1.4.Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1.Research Process of the Intrauterine Insemination Devices Market
  • 2.2.Research Methodology of the Intrauterine Insemination Devices Market
  • 2.3.Respondent Profile

3.MARKET SYNOPSIS

4.EXECUTIVE SUMMARY

5.IMPACT OF COVID-19 ON THE INTRAUTERINE INSEMINATION DEVICES MARKET

6.INTRAUTERINE INSEMINATION DEVICES MARKET REVENUE (USD BN), 2020-2030F

7.MARKET INSIGHTS BY PRODUCT TYPE

  • 7.1.Intrauterine Insemination Catheters
    • 7.1.1.Curved
    • 7.1.2.Flexible
    • 7.1.3.Straight
  • 7.2.Intrauterine Insemination Sperm Wash

8.MARKET INSIGHTS BY END USER

  • 8.1.Hospitals
  • 8.2.Clinics
  • 8.3.Others

9.MARKET INSIGHTS BY REGION

  • 9.1.North America
    • 9.1.1.U.S.
    • 9.1.2.Canada
    • 9.1.3.Rest of North America
  • 9.2.Europe
    • 9.2.1.Germany
    • 9.2.2.U.K.
    • 9.2.3.France
    • 9.2.4.Italy
    • 9.2.5.Spain
    • 9.2.6.Rest of Europe
  • 9.3.Asia-Pacific
    • 9.3.1.China
    • 9.3.2.Japan
    • 9.3.3.India
    • 9.3.4.Rest of Asia-Pacific
  • 9.4.Rest of World

10.INTRAUTERINE INSEMINATION DEVICES MARKET DYNAMICS

  • 10.1.Market Drivers
  • 10.2.Market Challenges
  • 10.3.Impact Analysis

11.INTRAUTERINE INSEMINATION DEVICES MARKET OPPORTUNITIES

12.INTRAUTERINE INSEMINATION DEVICES MARKET TRENDS

13.DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1.Demand Side Analysis
  • 13.2.Supply Side Analysis

14.VALUE CHAIN ANALYSIS

15.COMPETITIVE SCENARIO

  • 15.1.Competitive Landscape
    • 15.1.1.Porters Fiver Forces Analysis

16.COMPANY PROFILED

  • 16.1.CooperSurgical Fertility Company
  • 16.2.Cook Group Incorporated
  • 16.3.Vitrolife Sweden AB
  • 16.4.Kitazato Corporation
  • 16.5.FUJIFILM Irvine Scientific
  • 16.6.MEDGYN PRODUCTS, INC.
  • 16.7.Rocket Medical plc.
  • 16.8.Thomas Medical
  • 16.9.Femasys Inc.
  • 16.10.Allwin Medical Devices

17.DISCLAIMER